Followers | 438 |
Posts | 45331 |
Boards Moderated | 4 |
Alias Born | 05/11/2008 |
Thursday, December 31, 2020 7:25:46 AM
jmcai273
Dec. 31st, 12:36 am
For context about timing I just went thru Centripetal v Cisco from earlier this year. Case was stayed in Virginia District Court while patent reexamination happened so parallels are there.
June 2019 - Motion to lift stay entered
Sept 11, 2019 - Hearing to Lift Stay
Sept 18, 2019 - Motion to Lift Stay GRANTED
October 10 2019 - Scheduling Conference Held (Pretrial and Trial Scheduled)
March 2020 - Pretrial Held
April 2020 - Bench Trial Scheduled and began May 5th, 2020
October 5 2020 - OPINION ORDERED
Settlement Conferences happened all along the way as well and no settlement was ever reached...although I am sure Cisco now wishes it did. Court found CISCO liable for $755million in damages and enhanced the damages by a factor of 2.5 for an award of $1.889 Billion.
They came up with the award damage based on a percentage factor called the apportionment factor. For each revenue stream that used Centripetals patent, they used a percentage of those total sales numbers to define what was owed. The products that had patents CISCO were infringing upon had $21BILLION in Revenue. This was only over the course of 3 years and this is the guide the judge used to deliver damages. So imagine 11 years now of infringing and take even a tiny percent of that times Google search ad revenue and you get a few shekels.
The only difference in our case is we still need to have the Markman hearing...but most of the Claim Construction briefing was completed in 2010 before the stay was granted... so only the actual hearing remains. This would add another 3 months I would say.
Recent NLST News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:54:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:44:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:35:01 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/01/2024 09:32:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 02:38:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2024 02:52:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2023 01:30:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2023 02:22:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 01:30:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 09:01:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/15/2023 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/11/2023 01:53:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:45:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 01:30:27 AM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM